Literature DB >> 2333304

Functional characterization of individual human hematopoietic stem cells cultured at limiting dilution on supportive marrow stromal layers.

H J Sutherland1, P M Lansdorp, D H Henkelman, A C Eaves, C J Eaves.   

Abstract

A major goal of current hematopoiesis research is to develop in vitro methods suitable for the measurement and characterization of stem cells with long-term in vivo repopulating potential. Previous studies from several centers have suggested the presence in normal human or murine marrow of a population of very primitive cells that are biologically, physically, and pharmacologically different from cells detectable by short-term colony assays and that can give rise to the latter in long-term cultures (LTCs) containing a competent stromal cell layer. In this report, we show that such cultures can be used to provide a quantitative assay for human "LTC-initiating cells" based on an assessment of the number of clonogenic cells present after 5-8 weeks. Production of derivative clonogenic cells is shown to be absolutely dependent on the presence of a stromal cell feeder. When this requirement is met, the clonogenic cell output (determined by assessment of 5-week-old cultures) is linearly related to the input cell number over a wide range of cell concentrations. Using limiting dilution analysis techniques, we have established the frequency of LTC-initiating cells in normal human marrow to be approximately 1 per 2 X 10(4) cells and in a highly purified CD34-positive subpopulation to be approximately 1 per 50-100 cells. The proliferative capacity exhibited by individual LTC-initiating cells cultured under apparently identical culture conditions was found to be highly variable. Values for the number of clonogenic cells per LTC-initiating cell in 5-week-old cultures ranged from 1 to 30 (the average being 4) with similar levels being detected in positive 8-week-old cultures. Some LTC-initiating cells are multipotent as evidenced by their generation of erythroid as well as granulopoietic progeny. The availability of a system for quantitative analysis of the proliferative and differentiative behavior of this newly defined compartment of primitive human hematopoietic cells should facilitate future studies of specific genetic or microenvironmental parameters involved in the regulation of these cells.

Entities:  

Mesh:

Year:  1990        PMID: 2333304      PMCID: PMC53946          DOI: 10.1073/pnas.87.9.3584

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  36 in total

1.  Loss of immunoreactivity in long-term bone marrow culture.

Authors:  T M Dexter; E Spooncer
Journal:  Nature       Date:  1978-09-14       Impact factor: 49.962

2.  Enzymatic treatment of long-term human marrow cultures reveals the preferential location of primitive hemopoietic progenitors in the adherent layer.

Authors:  L Coulombel; A C Eaves; C J Eaves
Journal:  Blood       Date:  1983-08       Impact factor: 22.113

3.  Transient nature of early haematopoietic spleen colonies.

Authors:  M C Magli; N N Iscove; N Odartchenko
Journal:  Nature       Date:  1982-02-11       Impact factor: 49.962

4.  Limiting dilution assays for the determination of immunocompetent cell frequencies. I. Data analysis.

Authors:  C Taswell
Journal:  J Immunol       Date:  1981-04       Impact factor: 5.422

5.  Close range cell:cell interaction required for stem cell maintenance in continuous bone marrow culture.

Authors:  S A Bentley
Journal:  Exp Hematol       Date:  1981-03       Impact factor: 3.084

6.  The role of cells and their products in the regulation of in vitro stem cell proliferation and granulocyte development.

Authors:  T M Dexter; E Spooncer; D Toksoz; L G Lajtha
Journal:  J Supramol Struct       Date:  1980

7.  Cytological evidence for a relationship between normal hemotopoietic colony-forming cells and cells of the lymphoid system.

Authors:  A M Wu; J E Till; L Siminovitch; E A McCulloch
Journal:  J Exp Med       Date:  1968-03-01       Impact factor: 14.307

8.  Loss of stem cell repopulating ability upon transplantation. Effects of donor age, cell number, and transplantation procedure.

Authors:  D E Harrison; C M Astle
Journal:  J Exp Med       Date:  1982-12-01       Impact factor: 14.307

9.  THE EFFICIENT DESIGN OF TRANSPLANTABLE TUMOUR ASSAYS.

Authors:  E H PORTER; R J BERRY
Journal:  Br J Cancer       Date:  1963-12       Impact factor: 7.640

10.  In vitro studies on lymphocyte differentiation. I. Long term in vitro culture of cells giving rise to functional lymphocytes in irradiated mice.

Authors:  J W Schrader; S Schrader
Journal:  J Exp Med       Date:  1978-09-01       Impact factor: 14.307

View more
  75 in total

1.  Expansion in vitro of transplantable human cord blood stem cells demonstrated using a quantitative assay of their lympho-myeloid repopulating activity in nonobese diabetic-scid/scid mice.

Authors:  E Conneally; J Cashman; A Petzer; C Eaves
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-02       Impact factor: 11.205

2.  Replating of bioreactor expanded human bone marrow results in extended growth of primitive and mature cells.

Authors:  B O Palsson; D J Oh; M R Koller
Journal:  Cytotechnology       Date:  1995-01       Impact factor: 2.058

Review 3.  [Tumor stem cell research - basis and challenge for diagnosis and therapy].

Authors:  Heidrun Karlic; Harald Herrmann; Axel Schulenburg; Thomas W Grunt; Sylvia Laffer; Irina Mirkina; Rainer Hubmann; Medhat Shehata; Brigitte Marian; Edgar Selzer; Michael Pfeilstöcker; Elisabeth Pittermann; Ulrich Jäger; Hubert Pehamberger; Christoph Zielinski; Peter Valent
Journal:  Wien Klin Wochenschr       Date:  2010-07-22       Impact factor: 1.704

4.  Stem cell technology. Interview by Abi Berger.

Authors:  P A Fontes; A W Thomson
Journal:  BMJ       Date:  1999-11-13

5.  Ocular surface epithelia contain ABCG2-dependent side population cells exhibiting features associated with stem cells.

Authors:  Murat T Budak; Onder S Alpdogan; Mingyuan Zhou; Robert M Lavker; M A Murat Akinci; J Mario Wolosin
Journal:  J Cell Sci       Date:  2005-04-15       Impact factor: 5.285

6.  Expression of Pitx2 in stromal cells is required for normal hematopoiesis.

Authors:  Aurélie Kieusseian; Jalila Chagraoui; Cécile Kerdudo; Philippe-Emmanuel Mangeot; Philip J Gage; Nicole Navarro; Brigitte Izac; Georges Uzan; Bernard G Forget; Anne Dubart-Kupperschmitt
Journal:  Blood       Date:  2005-09-29       Impact factor: 22.113

7.  An in vitro model for cytogenetic conversion in CML. Interferon-alpha preferentially inhibits the outgrowth of malignant stem cells preserved in long-term culture.

Authors:  J J Cornelissen; R E Ploemacher; B W Wognum; A Borsboom; H C Kluin-Nelemans; A Hagemeijer; B Löwenberg
Journal:  J Clin Invest       Date:  1998-09-01       Impact factor: 14.808

8.  Effect of rhG-CSF on the mobilization of CD38 and HLA-DR subfractions of CD34+ peripheral blood progenitor cells.

Authors:  M L Lozano; F Ortuño; F de Arriba; M C Rosillo; J Rivera; I Heras; V Vicente
Journal:  Ann Hematol       Date:  1995-09       Impact factor: 3.673

9.  Nitric oxide suppression of human hematopoiesis in vitro. Contribution to inhibitory action of interferon-gamma and tumor necrosis factor-alpha.

Authors:  J P Maciejewski; C Selleri; T Sato; H J Cho; L K Keefer; C F Nathan; N S Young
Journal:  J Clin Invest       Date:  1995-08       Impact factor: 14.808

10.  P2Y-like receptor, GPR105 (P2Y14), identifies and mediates chemotaxis of bone-marrow hematopoietic stem cells.

Authors:  Byeong-Chel Lee; Tao Cheng; Gregor B Adams; Eyal C Attar; Nobuyuki Miura; Sean Bong Lee; Yoriko Saito; Ivona Olszak; David Dombkowski; Douglas P Olson; Julie Hancock; Peter S Choi; Daniel A Haber; Andrew D Luster; David T Scadden
Journal:  Genes Dev       Date:  2003-07-01       Impact factor: 11.361

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.